Evonik is investing US$100 million over the next five years [...]

SGD Pharma has reported a 27% reduction in Scope 1 [...]

Cyllene Therapeutics has raised €33 million in a Series C [...]

Novartis has agreed to acquire UK biotech Myricx Bio for [...]

Vect-Horus has entered a research collaboration and exclusive licence option [...]

Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]

SERB has completed its €115 million licensing agreement with Hansa [...]

Telum Therapeutics has raised €18 million in a Series A [...]

Estonian biotechnology company Icosagen has completed a €45 million expansion [...]

Elixirgen Therapeutics has signed an option agreement with Nippon Shinyaku [...]